SEER, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SEER, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $37.00K, a 60.87% increase year-over-year.
- SEER, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $14.00K.
- SEER, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $23.00K.
- SEER, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $41.00K, a 75.74% decline year-over-year.
- SEER, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $97.00K, a 96.91% decline from fiscal 2022.
- SEER, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $3.14M, a 66.47% increase from fiscal 2021.
- SEER, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $1.89M, a 1200.00% increase from fiscal 2020.
- SEER, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $145.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $37.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $14.00K 10-Q · filed 2026-08-11 | |
| 2025-06-30 | $23.00K 10-Q · filed 2026-08-11 | |
| 2023-12-31 | $97.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $41.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $20.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $30.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $3.14M 10-K · filed 2024-03-04 | |
| 2022-09-30 | $169.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $445.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $773.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $1.89M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $631.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $236.00K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $171.00K 10-Q · filed 2021-11-09 | |
| 2020-12-31 | $145.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $42.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $28.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $24.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |